|Mr. Steven A. Sherman||Exec. Chairman||100k||N/A||1946|
|Mr. Jack Peurach||Pres, CEO & Director||366.72k||N/A||1966|
|Mr. John F. Glenn||CFO & Sec.||332k||N/A||1962|
|Mr. William R. Shaw||Chief Commercial Officer||402.14k||N/A||1974|
|Ms. Rachael Adams||Global Director of Marketing & Strategic Growth||N/A||N/A||N/A|
|Mr. Anthony Pratt||US Director of Sales||N/A||N/A||N/A|
|Ms. Foon Lim Chwee||Pres of APAC||N/A||N/A||N/A|
|Mr. Jerome Wong||Corp. Controller||N/A||N/A||N/A|
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.
Ekso Bionics Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.